These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 31119485)

  • 21. Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database.
    Procházka V; Papajík T; Janíková A; Belada D; Kozák T; Šálek D; Sýkorová A; Móciková H; Campr V; Dlouhá J; Langová K; Fürst T; Trněný M
    Leuk Lymphoma; 2017 Mar; 58(3):601-613. PubMed ID: 27666539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients.
    Heilgeist A; McClanahan F; Ho AD; Witzens-Harig M
    Cancer; 2013 Jan; 119(1):99-106. PubMed ID: 22736411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic significance of the intra-follicular tumor cell proliferative rate in follicular lymphoma.
    Koster A; Tromp HA; Raemaekers JM; Borm GF; Hebeda K; Mackenzie MA; van Krieken JH
    Haematologica; 2007 Feb; 92(2):184-90. PubMed ID: 17296567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First external validation of the FLIPI-L score in a single-center series of patients with follicular lymphoma.
    Mozas P; Rivero A; Rivas-Delgado A; Correa JG; Condom M; Nadeu F; Giné E; Delgado J; Villamor N; Campo E; Magnano L; López-Guillermo A
    Hematol Oncol; 2022 Apr; 40(2):297-301. PubMed ID: 34845733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors in follicular lymphoma in the rituximab era: how to identify a high-risk patient?
    Prochazka V; Papajik T; Jarosova M; Indrak K
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Jun; 155(2):99-108. PubMed ID: 21804618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis of follicular lymphomas.
    Luminari S; Federico M
    Hematol Oncol; 2006 Jun; 24(2):64-72. PubMed ID: 16514592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.
    Giné E; Montoto S; Bosch F; Arenillas L; Mercadal S; Villamor N; Martínez A; Colomo L; Campo E; Montserrat E; López-Guillermo A
    Ann Oncol; 2006 Oct; 17(10):1539-45. PubMed ID: 16940035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
    Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G;
    J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic tools in follicular lymphomas.
    Luminari S; Cox MC; Montanini A; Federico M
    Expert Rev Hematol; 2009 Oct; 2(5):549-62. PubMed ID: 21083020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble interleukin-2 receptor level predicts survival in patients with follicular lymphoma treated with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy in the rituximab era.
    Procházka V; Papajík T; Faber E; Raida L; Kapitáňová Z; Langová K; Prouzová Z; Jarošová M; Indrák K
    Leuk Lymphoma; 2014 Jul; 55(7):1584-90. PubMed ID: 24180329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
    Richendollar BG; Pohlman B; Elson P; Hsi ED
    Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma.
    Mihaljevic B; Jelicic J; Andjelic B; Antic D; Markovic O; Petkovic I; Jovanovic MP; Trajkovic G; Bila J; Djurasinovic V; Sretenovic A; Vukovic V; Smiljanic M; Balint MT
    Int J Hematol; 2016 Dec; 104(6):692-699. PubMed ID: 27714586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is the follicular lymphoma international prognostic index better than the international prognostic index to identify high-risk follicular lymphoma patients?
    Etto LY; Silva VC; Inaoka RJ; Costa RP; Alves AC; Colleoni GW
    Leuk Lymphoma; 2007 Mar; 48(3):526-30. PubMed ID: 17454593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial Treatment of Early Stage and Low Tumor Burden Follicular Lymphoma.
    Cohen JB; Kahl BS
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):663-672. PubMed ID: 32586572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and Biological Prognostic Factors in Follicular Lymphoma.
    Patel AA; Smith SM
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):647-662. PubMed ID: 32586571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features, prognosis and treatment of follicular lymphoma.
    Salles GA
    Hematology Am Soc Hematol Educ Program; 2007; ():216-25. PubMed ID: 18024633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab in the therapy of stage III and IV follicular lymphoma: Results of the REFLECT 1 study of the Serbian Lymphoma Group.
    Popovic S; Jovanovic D; Mihaljevic B; Andjelkovic N; Marjanovic G; Marisavljevic D; Vlaisavljevic N; Popovic L; Salma S; Agic D; Milosevic R; Smiljanic M; Sretenović S; Djurdjević P; Markovic O; Hajder J; Govedarovic N
    J BUON; 2017; 22(2):487-494. PubMed ID: 28534374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of follicular non-Hodgkin's lymphoma.
    Maloney DG
    Curr Hematol Rep; 2005 Jan; 4(1):39-45. PubMed ID: 15610658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome.
    Sorigue M; Mercadal S; Alonso S; Fernández-Álvarez R; García O; Moreno M; Pomares H; Alcoceba M; González-García E; Motlló C; González-Barca E; Martin A; Sureda A; Caballero D; Ribera JM; Sancho JM
    Hematol Oncol; 2017 Dec; 35(4):520-527. PubMed ID: 28156010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Life expectancy of young adults with follicular lymphoma.
    Conconi A; Lobetti-Bodoni C; Montoto S; Lopez-Guillermo A; Coutinho R; Matthews J; Franceschetti S; Bertoni F; Moccia A; Rancoita PM; Gribben J; Cavalli F; Gaidano G; Lister TA; Montserrat E; Ghielmini M; Zucca E
    Ann Oncol; 2015 Nov; 26(11):2317-22. PubMed ID: 26362567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.